Safety and immunogenicity of Ad26.COV2.S in adolescents: phase 2 randomized clinical trial (2025)
- Authors:
- Autor USP: MUSSI, MARISA MARCIA - FMRP
- Unidade: FMRP
- DOI: 10.1080/21645515.2025.2450120
- Subjects: VACINAS; ADOLESCENTES; IMUNOGENICIDADE DA VACINA
- Keywords: Ad26.COV2.S; COVID-19 vaccine; Adolescent; Dose-range study; Immunogenicity; Safety; Shelf life; Virus vector vaccine
- Language: Inglês
- Imprenta:
- Source:
- Título: Human Vaccines & Immunotherapeutics
- ISSN: 2164-5515
- Volume/Número/Paginação/Ano: v. 21, n. 1, art. 2450120, p. 1-12, 2025
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
TICA, Jelena et al. Safety and immunogenicity of Ad26.COV2.S in adolescents: phase 2 randomized clinical trial. Human Vaccines & Immunotherapeutics, v. 21, n. 1, p. 1-12, 2025Tradução . . Disponível em: https://doi.org/10.1080/21645515.2025.2450120. Acesso em: 15 abr. 2026. -
APA
Tica, J., Rezelj, V. V., Baron, B., Zaidman, J., Fairlie, L., Scheper, G., et al. (2025). Safety and immunogenicity of Ad26.COV2.S in adolescents: phase 2 randomized clinical trial. Human Vaccines & Immunotherapeutics, 21( 1), 1-12. doi:10.1080/21645515.2025.2450120 -
NLM
Tica J, Rezelj VV, Baron B, Zaidman J, Fairlie L, Scheper G, Struyf F, Douoguih M, Le Gars M, Mussi MM. Safety and immunogenicity of Ad26.COV2.S in adolescents: phase 2 randomized clinical trial [Internet]. Human Vaccines & Immunotherapeutics. 2025 ; 21( 1): 1-12.[citado 2026 abr. 15 ] Available from: https://doi.org/10.1080/21645515.2025.2450120 -
Vancouver
Tica J, Rezelj VV, Baron B, Zaidman J, Fairlie L, Scheper G, Struyf F, Douoguih M, Le Gars M, Mussi MM. Safety and immunogenicity of Ad26.COV2.S in adolescents: phase 2 randomized clinical trial [Internet]. Human Vaccines & Immunotherapeutics. 2025 ; 21( 1): 1-12.[citado 2026 abr. 15 ] Available from: https://doi.org/10.1080/21645515.2025.2450120 - Quality assurance program for peripheral blood mononuclear cell cryopreservation
- Neurologic outcomes in HIV-exposed/uninfected infants exposed to antiretroviral drugs during pregnancy in Latin America and the Caribbean
- Undervaccination of perinatally HIV-infected and HIV-exposed uninfected children in Latin America and the Caribbean
- Clinical profile of HIV-infected adolescents in Latin America: preliminary report of NICHD international site development initiative pediatric study
- Recem-nascido de baixo peso
- NICDH International Site Developmental Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries
- Laboratory-based surveillance of streptococcus pneumoniae invasive disease (IPD) in children: serotype distribution and estimation of vaccines coverage
- Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants
- Congenital and perinatal cytomegalovirus infection
- Altered natural killerr cell function in HIV-exposed uninfected infants
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003250198.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
